AstraZeneca

Latest news

• Sam Fazeli: AstraZeneca's $2 Billion Summit Bet Tests Whether Strategics See What Public Markets Can't (opens in a new tab)

  finance.biggo.com · Oct 2, 2026

• AstraZeneca invests $2bn in Summit Therapeutics, deepening oncology ADC-bispecific ties (opens in a new tab)

  TipRanks · Oct 2, 2026

• AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3 (opens in a new tab)

  TradingView · Oct 2, 2026

• astrazeneca acquired rights to cspc experimental weight-loss drugs for billions (opens in a new tab)

  BusinessWorld Online · Oct 2, 2026

• AstraZeneca PLC, Daiichi Sankyo And Summit Therapeutics Inc. Announce Clinical Collaboration To Evaluate Datroway In Combination With Ivonescimab Across Multiple Tumour Types (opens in a new tab)

  marketscreener.com · Oct 2, 2026

• EU revokes Hansoh's Aumseqa nod after AstraZeneca challenge (opens in a new tab)

  FirstWord Pharma · Oct 2, 2026

• AstraZeneca, Daiichi Sankyo, and Summit to Combine Datroway, Ivonescimab (opens in a new tab)

  BioPharm International · Oct 2, 2026

• AstraZeneca et Daiichi Sankyo s'associent à Summit pour tester une association de médicaments anticancéreux (opens in a new tab)

  TradingView · Oct 2, 2026

• Summit to Pair with AstraZeneca, Daiichi Sankyo to Evaluate Ivonescimab as Combination Therapy (opens in a new tab)

  Contract Pharma · Oct 2, 2026

• AstraZeneca, Daiichi Sankyo partner with Summit to test Datroway-ivonescimab combinations (opens in a new tab)

  Dealroom · Oct 2, 2026

• AstraZeneca Trillion-Pound Valuation: Can the Pipeline Deliver It? (opens in a new tab)

  ABC Money · Oct 2, 2026

• Innovation roundup: Carnegie Mellon in Miami, AstraZeneca's $2B investment (opens in a new tab)

  bizjournals.com · Oct 2, 2026

• Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone (opens in a new tab)

  Endpoints News · Oct 2, 2026

• 
  AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact (opens in a new tab)

  Pharmaceutical Technology · Oct 2, 2026

• Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics (opens in a new tab)

  Pharmaceutical Executive · Oct 2, 2026

• AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership (opens in a new tab)

  Benzinga · Oct 2, 2026

• Rx Rundown: Eli Lilly, AstraZeneca, United Immunity and more (opens in a new tab)

  Medical Marketing and Media · Oct 2, 2026

• 
  Sanofi, Regeneron Expand Immunology Alliance With New Antibodies (opens in a new tab)

  Zacks · Oct 2, 2026

• SMMT Stock Gets Another Catalyst: Summit, AstraZeneca, Daiichi Sankyo Expand Cancer Drug Push (opens in a new tab)

  Stocktwits · Oct 2, 2026

• 
  Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial – CEO Calls It An ‘Important Expansion’ (opens in a new tab)

  Stocktwits · Oct 2, 2026

• 
  J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch (opens in a new tab)

  Zacks · Oct 2, 2026

• People on the Move: Maciej Szymaszek Named Head of Commercial AI Strategy at AstraZeneca (opens in a new tab)

  biobuzz.io · Oct 2, 2026

• AstraZeneca invests USD 2.00 billion and AstraZeneca stock costs EUR 141.25 (opens in a new tab)

  AD HOC NEWS · Oct 2, 2026

• AstraZeneca buys into Summit – this is only the beginning (opens in a new tab)

  Biostock · Oct 2, 2026

• AstraZeneca and Daiichi Sankyo Team With Summit on Datroway Combination Trials (opens in a new tab)

  AskTraders · Oct 2, 2026

• Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. (opens in a new tab)

  Stock Titan · Oct 2, 2026

• AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (opens in a new tab)

  srnnews.com · Oct 2, 2026

• AstraZeneca, Daiichi team with Summit to pair Datroway with ivonescimab in Phase III TNBC push (opens in a new tab)

  allsci.com · Oct 2, 2026

• 
  Summit Therapeutics (SMMT), What Is Behind The Fresh Attention? (opens in a new tab)

  Simply Wall St. · Oct 2, 2026

• Summit Therapeutics to test ivonescimab with AstraZeneca-Daiichi ADC (opens in a new tab)

  StreetInsider · Oct 2, 2026